Checkpoint Capital L.P.
SAN FRANCISCO, CA · CIK 1977548 · 13F filing filed 2024-08-14
SEC-registered investment adviser since 2025 · limited partnership
- Assets managed$333.8m
- Staff2 · 2 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds1 (1 hedge) · $333.8m gross assets
- Websitecheckpointlp.com
- Form ADV · 2026-03-27SEC adviser record
- Legal entityCheckpoint Capital L.P. (US)
- Kindhedge funds, futures
- Others nearbySan Francisco, CA
As an employer
- Offices in1 country
- Private fundshedge 1
$165.9m
reported value
+10.9% vs Q1 2024
16positions
95.1%in top 10
5 new
7 added
3 reduced
6 sold out
vs Q1 2024
Holdings, Q2 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| RHYTHM PHARMACEUTICALS INC RYTM | $37.9m22.82% | Added +96.6k |
| ARGENX SE ARGX | $35.3m21.30% | Added +150 |
| AXSOME THERAPEUTICS INC AXSM | $23.4m14.11% | Added +158.3k |
| AVADEL PHARMACEUTICALS PLC AVDL | $16.0m9.65% | New |
| PROTAGONIST THERAPEUTICS INC PTGX | $12.3m7.42% | Added +74.7k |
| CYTOKINETICS INC CYTK | $10.3m6.21% | Unchanged |
| PHATHOM PHARMACEUTICALS INC PHAT | $9.0m5.43% | Added +429.8k |
| CORCEPT THERAPEUTICS INC CORT | $8.0m4.79% | Reduced -29.0k |
| ATYR PHARMA INC ATYR | $3.0m1.83% | Added +500.0k |
| PLIANT THERAPEUTICS INC PLRX | $2.5m1.50% | New |
| KYMERA THERAPEUTICS INC KYMR | $2.4m1.48% | New |
| CIDARA THERAPEUTICS INC CDTX | $1.7m1.05% | New |
| TREVI THERAPEUTICS INC TRVI | $1.5m0.90% | Reduced -6.0k |
| APPLIED THERAPEUTICS INC APLT | $1.1m0.64% | Added +7.5k |
| SOLENO THERAPEUTICS INC SLNO | $803.6k0.48% | New |
| ALLAKOS INC ALLKG | $650.0k0.39% | Reduced -118.0k |
Sold out since Q1 2024
| Security | Value then |
|---|---|
| AVADEL PHARMACEUTICALS PLC | $11.8m701.4k shares |
| MIRUM PHARMACEUTICALS INC MIRM | $9.1m362.2k shares |
| IRONWOOD PHARMACEUTICALS INC IRWD | $5.4m618.5k shares |
| VERASTEM INC VSTM | $2.0m168.7k shares |
| GH RESEARCH PLC GHRS | $2.0m185.7k shares |
| ATARA BIOTHERAPEUTICS INC | $619.6k892.9k shares |